Evidence map›Paper›PMID 26648285›Full record

ArticleMolecular medicine reports2016

[Corrigendum] Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.

Dacai Xu, Jianglin Wang, Zhenkang Zhou, Zhiwei He, Qing Zhao

Abstract readPublished Erratum
In one paragraph

Article in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Dacai XuDepartment of Biochemistry, Guangzhou Medical University, Guangzhou, Guangdong 510182, P.R. China.
Jianglin WangDepartment of Biochemistry, Guangzhou Medical University, Guangzhou, Guangdong 510182, P.R. China.
Zhenkang ZhouSchool of Mathematics, South China University of Technology, Guangzhou, Guangdong 510640, P.R. China.
Zhiwei HeGuangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan, Guangdong 523376, P.R. China.
Qing ZhaoDepartment of Biochemistry, Guangzhou Medical University, Guangzhou, Guangdong 510182, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mol Med Rep 12: [Related article:] 7963–7970, 2015; DOI: 10.3892/mmr.2015.4477 Following the publication of this article, an interested reader drew to our attention an anomaly associated with the presentation of Fig. 4B. The images captured at the 0 h time point, illustrating the addition of the synthetic cannabinoid, WIN55, 212-2 (WIN), to the BEL7402 hepatocellular carcinoma cells (at concentrations of 5 and 10 µM; upper panels, the centre image and the right image, respectively) were inadvertently selected from the same original image. An error was made during the compilation of this Figure, and an incorrect image was selected for Fig. 4B, the upper right panel (showing the addition of 10 µM WIN). A corrected version of Fig 4 is presented, showing the correct data for Fig. 4B, which pertain to the 0 h time point on addition of 10 µM WIN to the cells. This error did not affect the overall conclusions reported in the present study. We sincerely apologize for this mistake, and thank the reader of our article who drew this matter to our attention. Furthermore, we regret any inconvenience this mistake has caused.

Identifiers

PMID26648285
PMCPMC6918822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.